Early work on the function of Bcl-2, an interview with David Vaux.
Vaux
David  L
D
D000818:Animals; D017209:Apoptosis / Q000502:physiology; D051017:Apoptosis Regulatory Proteins; D001315:Australia; D029742:Caenorhabditis elegans Proteins / Q000235:genetics / Q000502:physiology; D016923:Cell Death / Q000502:physiology; D002471:Cell Transformation, Neoplastic / Q000235:genetics; D006133:Growth Substances / Q000502:physiology; D049673:History, 20th Century; D006801:Humans; D008224:Lymphoma, Follicular / Q000235:genetics; D009369:Neoplasms / Q000209:etiology / Q000235:genetics; D010827:Physiology / Q000266:history*; D011518:Proto-Oncogene Proteins / Q000235:genetics / Q000502:physiology; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000235:genetics / Q000266:history / Q000502:physiology*; D016271:Proto-Oncogene Proteins c-myc / Q000235:genetics / Q000502:physiology; D014481:United States
D051017:Apoptosis Regulatory Proteins; D029742:Caenorhabditis elegans Proteins; C087233:Ced-9 protein, C elegans; D006133:Growth Substances; D011518:Proto-Oncogene Proteins; D019253:Proto-Oncogene Proteins c-bcl-2; D016271:Proto-Oncogene Proteins c-myc